Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smartwatch-Based Heart Rate Detection in Atrial, Ventricular and Pulseless Arrhythmias.

Heart, lung & circulation·2026
Same author

Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular care.

The Lancet regional health. Western Pacific·2026
Same author

Screening for hypertension in a public dental clinic: A single-centre cross-sectional study in Australia.

PloS one·2026
Same author

Impact of atrial fibrillation on clinical outcomes in 28,492 patients following open-heart cardiac valve surgery: A statewide population-linkage study.

BMC medicine·2026
Same author

Dietary Approaches to Stop Hypertension (DASH) Diet, Incident Heart Failure and Its Associated Risk Factors in Australian Women.

Medicina (Kaunas, Lithuania)·2026
Same author

Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage.

The New England journal of medicine·2026
Same journal

The Absent Original in Smartphone Photography.

JAMA dermatology·2026
Same journal

A Tribute to a Master Clinician: Richard Odom.

JAMA dermatology·2026
Same journal

Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical Trial.

JAMA dermatology·2026
Same journal

Multiple Verrucous Plaques Along Blaschko Lines on the Left Lower Limb.

JAMA dermatology·2026
Same journal

The Absent Original in Smartphone Photography-Reply.

JAMA dermatology·2026
Same journal

Progression From Acute to Chronic Urticaria: A Systematic Review.

JAMA dermatology·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Text Messaging for Cardiovascular Risk Prevention in Psoriasis: A Randomized Clinical Trial.

Annika Smith1,2,3, Ishana Dixit1,2, Lois Zhang1,2

  • 1Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

JAMA Dermatology
|May 13, 2026
PubMed
Summary
This summary is machine-generated.

A text-messaging intervention significantly improved patient activation and cardiovascular risk behaviors in psoriasis patients. This digital health approach supports integrating cardiovascular risk management into dermatology care.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Experiment Videos

Last Updated: May 14, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Area of Science:

  • Dermatology and Cardiovascular Health
  • Digital Health Interventions
  • Patient Engagement

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in psoriasis patients.
  • Structured CVD prevention is often lacking in routine dermatology care.

Purpose of the Study:

  • To assess the effectiveness of a text-messaging intervention on patient activation and CVD risk factors in psoriasis patients.
  • To evaluate the TEXTME PSO intervention compared to standard care.

Main Methods:

  • A 6-month randomized clinical trial involving 111 adults with psoriasis.
  • Intervention group received 4 weekly text messages (TEXTME PSO); control group received standard care.
  • Primary outcome: Patient Activation Measure; secondary outcomes: diet, physical activity, and CVD knowledge.

Main Results:

  • The intervention group showed significant improvements in patient activation (P < .001), Mediterranean diet adherence (P < .001), medication adherence (P < .001), and psoriasis-CVD knowledge (P < .001).
  • Increased physical activity (P = .02) and reduced BMI (P < .001) were observed.
  • No significant differences in lipid parameters, HbA1c, smoking, or psoriasis severity.

Conclusions:

  • A text-messaging intervention effectively enhanced patient activation and cardiovascular risk behaviors in adults with psoriasis.
  • Digital tools can complement dermatology care for managing cardiovascular risk in this population.
  • While biomarker changes were modest, the intervention shows promise for improving patient engagement and health behaviors.